Nathalie Dubois

Head Of Pharmacovigilance at MeiraGTx

Nathalie Dubois has extensive experience in the field of pharmacovigilance, with roles at various companies over the years. Nathalie currently serves as the Head of Pharmacovigilance at MeiraGTx since September 2021. Prior to this, they worked at Sanofi as the QPPV System Support Manager from January 2019 to August 2021.

Before joining Sanofi, Nathalie was employed at Ablynx from April 2017 to December 2018, where they held the position of Sr. Pharmacovigilance Scientist and Deputy QPPV. During their time at Ablynx, they established a pharmacovigilance department for clinical trials and post-marketing, implemented a compliant PV system, and ensured oversight on PV vendor activities.

Nathalie also worked at Omega Pharma, A Perrigo Company, where they held multiple roles. From June 2016 to March 2017, they served as the Sr. Pharmacovigilance Operations Specialist and Deputy QPPV, taking on QPPV responsibilities in the absence of the QPPV. From May 2014 to June 2016, they were the Deputy QPPV, involved in various activities such as writing and maintaining company PV documents, implementing GvP modules, preparing for PV inspections, and improving the management of adverse event reports.

Nathalie's career in pharmacovigilance began at EORTC, where they worked from 1998 to 2014. Nathalie held the position of Head of Pharmacovigilance Unit from January 2003 to May 2014 and previously served as the Safety Desk Manager from May 1998 to December 2002. In these roles, they implemented a safety desk, developed SOPs and software systems, and ensured compliance with European laws.

Overall, Nathalie Dubois has a wealth of experience in pharmacovigilance, with roles involving the establishment of PV departments, implementation of PV systems, oversight on vendor activities, and maintaining compliance with regulatory requirements.

Nathalie Dubois obtained their Master in Nutrition and Dietary Sciences from KU Leuven, where they studied from 1992 to 1998. During the same period, they also enrolled in a clinical trial called CARMEN at Maastricht University. Prior to their university education, they attended Onze-Lieve-Vrouwecollege Oostende from 1986 to 1992, where they studied Human Sciences. There is no information available about Nathalie's education before attending Onze-Lieve-Vrouwecollege Oostende.

In terms of additional certifications, Nathalie completed a course titled "Professional Development: Improve Yourself, Always" from Coursera in July 2020. Nathalie also obtained the Eudravigilance QPPV certification from EMA, but the specific month and year are not provided.

Links

Previous companies

Sanofi logo
EORTC logo

Timeline

  • Head Of Pharmacovigilance

    September, 2021 - present

View in org chart